arrow
G

Giacomo Caldarola

università cattolica del sacro cuore
H指数:28
被引数:2,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LC-OCT for Cutaneous Lupus Erythematosus: Characterization Across Disease Subtypes and Differentiation From Rosacea

利用LC-OCT对皮肤红斑狼疮进行表征:跨疾病亚型的特征分析及与玫瑰痤疮的鉴别

2026-09-290
OAAI
Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study
2026-09-010
PRE
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology

免疫介导性疾病中的创新与可持续性:意大利胃肠病学、皮肤病学和风湿病学多学科共识

2026-06-030
OAAI
Long-Term Persistence with Guselkumab: A 5-Year Multicenter Retrospective Study across 14 Dermatology Centers in Italy

guselkumab的长期持续性:一项在意大利14个皮肤病学中心进行的为期5年的多中心回顾性研究

2025-10-010
OAAI
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results

巴瑞替尼在严重斑秃中的有效性与安全性:48周结果

2025-09-230
PRE
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study

银屑病患者中 guselkumab 的长期真实世界有效性与药物生存率:一项为期5年的回顾性研究

2025-09-160
OA
Predictive factors for eczematous eruptions and candidiasis during anti-interleukin-17 treatment in patients with psoriasis: a multicentre real-life experience in Lazio region, Italy

银屑病患者接受抗白细胞介素-17治疗期间湿疹样皮疹和念珠菌病的预测因素:意大利拉齐奥地区多中心真实世界经验研究

2025-07-013
OA
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?

乌帕替尼在治疗中重度特应性皮炎中的应用:患者特征分析、剂量选择和治疗调整,现实世界能告诉我们什么?

2025-06-090
OA